Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Rovner

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
International Urogynecology Journal|December 4, 2010
Predicting for postoperative incontinence following sling incisionTimothy Yoost, Ross Rames, Brett Lebed, et al.
Neurourology and Urodynamics|April 8, 2015
Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivityEmmanuel Chartier-Kastler, Eric Rovner, Zsolt Hepp, et al.
Neurourology and Urodynamics|February 8, 2013
OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivityEric Rovner, Roger Dmochowski, Christopher Chapple, et al.
The Journal of Urology|May 6, 2024
Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE TrialDavid Staskin, Janet Owens-Grillo, Elizabeth Thomas, et al.
Neurourology and Urodynamics|February 4, 2026
What Are the Limitations of Measuring Bladder Compliance, As the Sole Indicator of Future Risk to the Upper Urinary Tract and Renal Function? ICI-RS 2025Eric Rovner, Marcus J Drake, Solomon Eskinder, et al.
Neurourology and Urodynamics|February 8, 2020
Is polypropylene mesh material fundamentally safe for use as a reconstructive material in vaginal surgery: ICI-RS 2019?Eric Rovner, Renaud de Tayrac, Ruth Kirschner-Hermanns, et al.
European Urology Open Science|November 29, 2023
The Effects of Age, Gender, and Postvoid Residual Volume on Catheterization Rates After Treatment with OnabotulinumtoxinA for Overactive BladderRoger Dmochowski, Christopher Chapple, Jennifer Gruenenfelder, et al.
Urology|November 30, 2014
Simple vs complex urethral diverticulum: presentation and outcomesSamuel Walker Nickles, Gini Ikwuezunma, Lara MacLachlan, et al.
Urology|August 8, 2009
Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopicallyDeborah Lightner, Eric Rovner, Jacques Corcos, et al.
Neurourology and Urodynamics|February 26, 2011
Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladderEric Rovner, Michael Kennelly, Heinrich Schulte-Baukloh, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
International Urogynecology Journal|December 4, 2010
Predicting for postoperative incontinence following sling incisionTimothy Yoost, Ross Rames, Brett Lebed, et al.
Neurourology and Urodynamics|April 8, 2015
Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivityEmmanuel Chartier-Kastler, Eric Rovner, Zsolt Hepp, et al.
Neurourology and Urodynamics|February 8, 2013
OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivityEric Rovner, Roger Dmochowski, Christopher Chapple, et al.
The Journal of Urology|May 6, 2024
Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE TrialDavid Staskin, Janet Owens-Grillo, Elizabeth Thomas, et al.
Neurourology and Urodynamics|February 4, 2026
What Are the Limitations of Measuring Bladder Compliance, As the Sole Indicator of Future Risk to the Upper Urinary Tract and Renal Function? ICI-RS 2025Eric Rovner, Marcus J Drake, Solomon Eskinder, et al.
Neurourology and Urodynamics|February 8, 2020
Is polypropylene mesh material fundamentally safe for use as a reconstructive material in vaginal surgery: ICI-RS 2019?Eric Rovner, Renaud de Tayrac, Ruth Kirschner-Hermanns, et al.
European Urology Open Science|November 29, 2023
The Effects of Age, Gender, and Postvoid Residual Volume on Catheterization Rates After Treatment with OnabotulinumtoxinA for Overactive BladderRoger Dmochowski, Christopher Chapple, Jennifer Gruenenfelder, et al.
Urology|November 30, 2014
Simple vs complex urethral diverticulum: presentation and outcomesSamuel Walker Nickles, Gini Ikwuezunma, Lara MacLachlan, et al.
Urology|August 8, 2009
Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopicallyDeborah Lightner, Eric Rovner, Jacques Corcos, et al.
Neurourology and Urodynamics|February 26, 2011
Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladderEric Rovner, Michael Kennelly, Heinrich Schulte-Baukloh, et al.
Pageof 4